CompletedPhase 3

Effect of Intracameral Injection of Mydriatic Plus Anaesthetic Combination on Corneal Endothelial Count in Phaco

Egypt30 participantsStarted 2019-02-01

Plain-language summary

Study evaluates safety of intracameral injection of Fydrane (tropicamide 0.02%, phenylephrine 0.31% and lidocaine 1%) on corneal endothelium, and efficiency in maintaining pupillary dilatation during phacoemulsification surgery.

Who can participate

Age range60 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * medium density cataract (nuclear II to III) Exclusion Criteria: * soft or hard density cataract (nuclear I or IV) * history of ocular trauma or previous intraocular surgery * iatrogenic, congenital or traumatic cataract * associated eye disease e.g. pseudoexofoliation syndrome * associated pre-existing corneal endothelial disease e.g. Fuchs dystrophy * associated systemic disease that can affect endothelium,

What they're measuring

safety of intracameral Fydrane on endothelial cell count

Timeframe: 3 weeks postoperative

Trial details

NCT IDNCT04396301

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-08-30

View on ClinicalTrials.gov More Corneal Endothelial Cell Loss trials